FIELD: pharmaceutics.
SUBSTANCE: invention relates to a new 2-styryl derivative of 4-(2,6-dimethyl-4-oxo-5-phenyl-4H-pyrimidine-1-yl)-benzsulfamide of formula (I) having endothelioprotective activity, and to a method for its preparation. Compound can be used in the manufacture of medicines for cardiology and endocrinology. Compound affects on the induced vasodilation, the rate of platelet aggregation, the level of von Willebrand factor, fibrinogen, endothelial nitric oxide synthase, asymmetric dimethyl arginine, matrix metalloproteinase-1 and protein kinase-C against endothelial dysfunction and exceeds the known drug sulodexide in activity. Compound corresponds to formula .
EFFECT: method for the preparation of a compound of formula (I) is the reaction of 4-(2,6-dimethyl-4-oxo-5-phenyl-4H-pyrimidine-1-yl)-benzsulfamide with salicylic aldehyde in a mixture of ethanol and dimethyl sulfoxide as the reaction medium.
3 cl, 8 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF BIOFLAVONOIDS HESPERIDIN AND PINOSTROBIN POSSESSING ENDOTHELIUM PROTECTIVE, ANTICOAGULANT AND ACTOPROTECTIVE ACTION | 2014 |
|
RU2575790C2 |
SOLUTION WITH OF ENDOTHELIOPROTECTIVE POTENCY | 2017 |
|
RU2643605C1 |
PHARMACEUTICAL COMPOSITION, MADE OF VICIA ABBREVIATA HERB USED AS ENDOTELYOPROTECTIVE AGENT | 2015 |
|
RU2653468C2 |
HERBAL MEDICINAL PRODUCT HAVING ENDOTHELIOPROTECTIVE ACTIVITY | 2014 |
|
RU2561064C1 |
COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
METHOD OF TREATING ENDOTHELIAL DYSFUNCTION IN DIABETES MELLITUS | 2019 |
|
RU2703567C1 |
METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING MODEL OF L-NAME-INDUCED NITRIC OXIDE DEFICIENCY | 2023 |
|
RU2810415C1 |
SODIUM SALT OF 4-{ 2-[2-(4- HYDROXY-3-METHOXYPHENYL)-VINYL]-6-ETHYL-4-OXO-5-PHENYL-4H-PYRIMIDINE-1-YL} -BENZENESULFAMIDE, WHICH HAS AN ANTITUMOR EFFECT | 2021 |
|
RU2763899C1 |
USE OF OXATHRIAZOLO-5-OLATE FOR TREATING SEXUAL DISORDERS | 2014 |
|
RU2600845C2 |
3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE -3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE NICOTINATE DERIVATIVE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 |
|
RU2465268C1 |
Authors
Dates
2018-05-04—Published
2017-06-07—Filed